Related Experiment Videos
RAMEDIS- rare metabolic diseases publishing tool for genotype-phenotype correlation
U Mischke1, U Scholz, T Toepel
1Children's Hospital Reutlingen, Reutlingen, Germany. grn.kkh-rt@t-online.de
Studies in Health Technology and Informatics
|October 18, 2001
Summary
A new global internet-based data collection method, RAMEDIS, standardizes patient data for rare genetic diseases. This facilitates statistics, longitudinal studies, and phenotype-genotype correlations, improving patient care and diagnosis.
Area of Science:
- Genetics
- Medical Informatics
- Rare Diseases
Background:
- Rare genetic diseases present challenges in data collection and research due to limited patient populations.
- Existing methods for collecting data from single case reports are often insufficient for comprehensive analysis.
- The German Human Genome Project aims to advance understanding of human genetics.
Purpose of the Study:
- To establish a worldwide internet-based method for collecting standardized patient data on rare genetic diseases.
- To enable phenotype-genotype correlations for rare genetic disorders.
- To improve the characterization of clinical heterogeneity and treatment of rare diseases.
Main Methods:
- Implementation of a data collection system named RAMEDIS (Rare Disease Information System).
- Utilizing the Oracle database management system for standardized data storage.
- Online submission of patient case reports since November 2000.
Main Results:
- RAMEDIS enables the collection of standardized patient data from single case reports globally.
- The system supports future statistical analyses, longitudinal examinations, and cooperative studies.
- Facilitates direct phenotype-genotype correlations within the German Human Genome Project framework.
Conclusions:
- The RAMEDIS system enhances the characterization of clinical heterogeneity in rare diseases.
- Improved data collection and analysis can lead to better diagnostic processes and therapies for patients with rare genetic conditions.
- This approach offers a cost-effective solution for research on rare diseases where prospective studies are difficult.